strong/stronga href="http://1.bp.blogspot.com/_ngczZkrw340/SWJCBADk-EI/AAAAAAAAMBE/lRuGq1QvY5c/s1600-h/cafe+fiorino.png"img id="BLOGGER_PHOTO_ID_5287861497448691778" style="DISPLAY: block; MARGIN: 0px auto 10px; WIDTH: 241px; CURSOR: hand; HEIGHT: 320px; TEXT-ALIGN: center" alt="" src="http://1.bp.blogspot.com/_ngczZkrw340/SWJCBADk-EI/AAAAAAAAMBE/lRuGq1QvY5c/s320/cafe+fiorino.png" border="0" //abr /br /by Edward Hugh: Barcelonabr /br /br /Spain's inflation (as measured by the EU HICP methodology) was around 1.5% (year on year) in December 2008, according to the flash estimate issued by the stats office (INE) earlier this week. This number only offers us an initial glimpse of the final HICP reading, but, if confirmed, it will mean Spain's annual rate of inflation has dropped 0.9% (nearly one full percentage point) in the space 0f just one month - since in November the annual rate was 2.4%.br /br /a href="http://3.bp.blogspot.com/_ngczZkrw340/SWHrDP6v8KI/AAAAAAAAL_M/-UWmp9lHkN8/s1600-h/spain+CPI.png"img id="BLOGGER_PHOTO_ID_5287765878554751138" style="DISPLAY: block; MARGIN: 0px auto 10px; WIDTH: 320px; CURSOR: hand; HEIGHT: 187px; TEXT-ALIGN: center" alt="" src="http://3.bp.blogspot.com/_ngczZkrw340/SWHrDP6v8KI/AAAAAAAAL_M/-UWmp9lHkN8/s320/spain+CPI.png" border="0" //abr /br /It will also mean that Spain's inflation for 2007 dropped its the lowest rate in a decade, down sharply ...

Looking at the wide variety of companies working to make a go of their business makes one wonder when and if any of them will actually make the leap from development to profitable. So many companies struggle through the year, with only a hope of breaking through. Every once in a while, however, a company makes the leap after laying out millions to get their product to market. Being willing to take the risk and invest is where the savvy investor profits. The risk remains, but it can certainly result in a nice profit.

MAP Pharmaceuticals Inc., a development stage drug company, works to develop pharmaceutical type medications primarily directed at pediatric asthma, non-pediatric asthma, migraines and diabetes. The company is more specifically involved in nebulized medications and cardiac inhaler delivery systems.

To imply that the company is more oriented toward the delivery system of the medications it develops would be

...

Great day to be looking for bargains, hopefully a few of you made the switch to Cash last week or Monday.  As always, the insightful Hilary Kramer made an appearance on the Nightly Business Report. Let's review her commentary... Street Critique"-Hilary Kramer, Chief Market Strategist at GreenTech ResearchWednesday, September 03, 2008 Tickers Mentioned: BMI, ZOLT, AMSC PAUL KANGAS: Tonight's "Street Critique" guest says this is one of the worst ...